01
Cyber Attacks / Data Breach
Cyber attacks are, and will remain, a top risk across all geographies and industry sectors. All leaders need a cyber game plan.
From early-stage biotechnology start-ups to large multinational pharmaceuticals, the life sciences industry relies on innovation to meet shifting demands in health and improve treatment outcomes around the globe. However, emerging and established risks force organizations to operate in a volatile environment. While navigating research and development challenges, supply chain impacts and barriers to commercial sales, businesses also find themselves swept up in the fight for talent.
Finding new ways to cost-effectively manage risk and attract and retain a digitally-savvy workforce will accelerate innovation to create greater efficiencies, develop personalized medical treatments and access new markets. But with ever-evolving regulation, governance and production interruptions impacting the pace of progress, businesses across this sector must be resilient, investing in end-to-end solutions for their risk and human capital, as well as workforce health and wellbeing to protect vital talent.
Looking ahead to 2024, predicted risks for the life sciences industry include:
Stay in the loop on today's most pressing cyber security matters.
Explore Aon's latest environmental social and governance (ESG) insights.
Explore our hand-picked insights for human resources professionals.
How do businesses navigate their way through new forms of volatility and make decisions that protect and grow their organizations?
Article 16 Min Read
In a move designed to close the gender pay gap, the European Commission is increasing pay transparency across member states. Prepare your firm now for potential implications and opportunities.
Article 22 Min Read
An alarming number of insured Americans still can’t afford healthcare treatment, but there are approaches employers can take to reduce costs and improve outcomes for employees and their families.
Article 22 Min Read
AI is creating new possibilities in life sciences, especially in R&D, training and marketing. But, as the industry adapts to AI, it also faces risks and challenges.